Market revenue in 2023 | USD 26.0 million |
Market revenue in 2030 | USD 34.5 million |
Growth rate | 4.1% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 50% in 2023. Horizon Databook has segmented the UAE interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
The prevalence of CVDs in the UAE is on the rise due to factors such as lifestyle changes, increasing obesity rates, and growing adoption of a sedentary lifestyle. According to the WHO, NCDs, including CVDs, account for 63% of deaths in the UAE.
Companies operating in the UAE's interventional cardiology market are constantly seeking partnerships and collaborations to expand their product portfolios and enhance their market presence.Hospitals in the country play a crucial role in rendering cardiovascular interventions due to their comprehensive range of services, specialized expertise, and accessibility.
For instance, in February 2022, Aster Hospital, Dubai, used a novel dissolving stent for the treatment of a blockage in the heart artery in a patient suffering from coronary stenosis. Few studies conducted by Aster Hospital highlight that blockage development starts at an early age among Southeast Asian patients as compared with patients from the West.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE interventional cardiology devices market , including forecasts for subscribers. This country databook contains high-level insights into UAE interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account